Similar companies
Income Statement (USD)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 59.7B | 8.8% |
Gross Profit | 1.85B | 4.2% |
Cost of Revenue | 57.9B | 9.2% |
Operating expense | 1.45B | 2.1% |
Net Income | 236M | 9.6% |
EBITDA | 506M | 15.8% |
Balance Sheet (USD)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 45.1B | 1.7% |
Total Liabilities | 48.3B | 1.7% |
Shares Outstanding | 245M | 0.8% |
Cash Flow (USD)
Q2 '24 | QoQ | |
---|---|---|
Cash from operations | 2.08B | 4338.8% |
Cash from investing | 166M | 109% |
Cash from financing | -859M | 183.3% |
EPS
Financial Highlights for Cardinal Health in Q2 '24
Cardinal Health reported a revenue of 59.7B, which is a 8.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 1.85B, marking a -4.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 57.9B, a 9.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 1.45B, showing a -2.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 236M, showing a -9.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 506M, showing a 15.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Cardinal Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.